AbbVie’s $63 Billion Allergan Deal Gives Life to Industry

(Bloomberg) -- AbbVie Inc.’s deal to buy Botox maker Allergan Plc for $63 billion is reviving excitement on Wall Street for makers of specialty and generic drugs, at least for today.

Bloomberg Quint

Add BloombergQuint App to Home screen.